Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly
recognized group of disorders characterized by the extracellular deposition of misfolded …

Cardiac amyloidosis or amyloid cardiomyopathy (ACM), commonly resulting from
extracellular deposition of amyloid fibrils consisted of misfolded immunoglobulin light chain …

Objectives The aim of this study was to assess the diagnostic accuracy of bone scintigraphy
in a large multicenter cohort of patients with cardiac amyloidotic involvement and Phe64Leu …

Left ventricular (LV) hypertrophy consists in an increased LV wall thickness. LV hypertrophy
can be either secondary, in response to pressure or volume overload, or primary, ie not …

Cardiac amyloidosis (CA) is caused by deposition of amyloid fibrils in the myocardium and
has two main subtypes, transthyretin cardiac amyloidosis (ATTR) and immunoglobulin light …

Background 99m Tc-PYP scintigraphy provides differential diagnosis of ATTR
cardiomyopathy (ATTR-CM) from light chain cardiac amyloidosis and other myocardial …

Background Conventional nuclear imaging with bone-seeking radiopharmaceuticals has
been shown to be a sensitive test for the detection of transthyretin cardiac amyloidosis …

Background 99mTc-HMDP scintigraphy has proved its efficacy in non-invasive diagnosis of
cardiac amyloidosis (CA) and is currently interpreted according to the Perugini qualitative …

Amyloidosis is a progressive infiltrative disease instigated by the extracellular deposition of
amyloid fibrils in various organs such as the heart, kidney, and peripheral nerves. Cardiac …

There has been a transformation over the past decade in the diagnosis and management of
patients with amyloid transthyretin (ATTR) cardiac amyloidosis which has been driven by the …